These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1990009)

  • 61. Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms.
    Steinmann B; Nicholls A; Pope FM
    J Biol Chem; 1986 Jul; 261(19):8958-64. PubMed ID: 3722184
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix.
    Makareeva E; Cabral WA; Marini JC; Leikin S
    J Biol Chem; 2006 Mar; 281(10):6463-70. PubMed ID: 16407265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
    Yang W; Battineni ML; Brodsky B
    Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An alpha2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta.
    Forlino A; Keene DR; Schmidt K; Marini JC
    Matrix Biol; 1998 Dec; 17(8-9):575-84. PubMed ID: 9923651
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.
    Galicka A; Wołczyński S; Gindzieński A; Surazyński A; Pałka J
    Mol Cell Biochem; 2003 Jun; 248(1-2):49-56. PubMed ID: 12870654
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gly85 to Val substitution in pro alpha 1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion.
    Valli M; Zolezzi F; Mottes M; Antoniazzi F; Stanzial F; Tenni R; Pignatti P; Cetta G
    Eur J Biochem; 1993 Oct; 217(1):77-82. PubMed ID: 8223589
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.
    Lamande SR; Dahl HH; Cole WG; Bateman JF
    J Biol Chem; 1989 Sep; 264(27):15809-12. PubMed ID: 2777764
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
    Wallis GA; Starman BJ; Zinn AB; Byers PH
    Am J Hum Genet; 1990 Jun; 46(6):1034-40. PubMed ID: 2339700
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1).
    Constantinou CD; Pack M; Young SB; Prockop DJ
    Am J Hum Genet; 1990 Oct; 47(4):670-9. PubMed ID: 2220807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Three unrelated individuals with perinatally lethal osteogenesis imperfecta resulting from identical Gly502Ser substitutions in the alpha 2-chain of type I collagen.
    Rose NJ; Mackay K; De Paepe A; Steinmann B; Punnett HH; Dalgleish R
    Hum Genet; 1994 Nov; 94(5):497-503. PubMed ID: 7959683
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Stacey A; Bateman J; Choi T; Mascara T; Cole W; Jaenisch R
    Nature; 1988 Mar; 332(6160):131-6. PubMed ID: 2450280
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two novel distinct COL1A2 mutations highlight the complexity of genotype-phenotype correlations in osteogenesis imperfecta and related connective tissue disorders.
    Reuter MS; Schwabe GC; Ehlers C; Marschall C; Reis A; Thiel C; Graul-Neumann L
    Eur J Med Genet; 2013 Dec; 56(12):669-73. PubMed ID: 24140640
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deletion of 19 base pairs in intron 13 of the gene for the pro alpha 2(I) chain of type-I procollagen (COL1A2) causes exon skipping in a proband with type-I osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Nakayasu K; Prockop DJ
    Hum Genet; 1993 Apr; 91(3):210-6. PubMed ID: 7916744
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A 9-base pair deletion in COL1A1 in a lethal variant of osteogenesis imperfecta.
    Hawkins JR; Superti-Furga A; Steinmann B; Dalgleish R
    J Biol Chem; 1991 Nov; 266(33):22370-4. PubMed ID: 1939261
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A heterozygous defect for structurally altered pro-alpha 2 chain of type I procollagen in a mild variant of osteogenesis imperfecta. The altered structure decreases the thermal stability of procollagen and makes it resistant to procollagen N-proteinase.
    Sippola M; Kaffe S; Prockop DJ
    J Biol Chem; 1984 Nov; 259(22):14094-100. PubMed ID: 6438090
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype.
    Wenstrup RJ; Cohn DH; Cohen T; Byers PH
    J Biol Chem; 1988 Jun; 263(16):7734-40. PubMed ID: 2897363
    [TBL] [Abstract][Full Text] [Related]  

  • 80. (G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I: effect of alpha-chain stoichiometry on the phenotype of osteogenesis imperfecta?
    Lund AM; Skovby F; Schwartz M
    Hum Mutat; 1997; 9(5):431-6. PubMed ID: 9143923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.